Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT04130542 |
| Title | Phase 1 Trial of LVGN6051 as Single Agent and in Combination Therapy in Advanced or Metastatic Malignancy |
| Recruitment | Active, not recruiting |
| Gender | both |
| Phase | Phase I |
| Variant Requirements | No |
| Sponsors | Lyvgen Biopharma Holdings Limited |
| Indications | |
| Therapies | |
| Age Groups: | adult | senior |
| Covered Countries | USA |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| University of California Irvine Health | Orange | California | 92868 | United States | Details | |
| UCSF Helen Diller Family Comprehensive Cancer Center | San Francisco | California | 94115 | United States | Details | |
| Verdi Oncology Research | Lafayette | Indiana | 47905 | United States | Details | |
| The Johns Hopkins University | Baltimore | Maryland | 21205 | United States | Details | |
| Nebraska Cancer Specialist | Omaha | Nebraska | 68130 | United States | Details | |
| NYU Langone Health | New York | New York | 10016 | United States | Details | |
| MD Anderson Cancer Center | Houston | Texas | 77030-3722 | United States | Details |